Weill Cornell Medicine researchers received a $2.4 million grant from the U.S. Department of Defense Breast Cancer Research Program to evaluate a test that uses an artificial intelligence algorithm to determine whether a patient is positive for cancer.
Collaboration was the theme of the evening at the second annual Community Engagement Awards, held April 16 and hosted by the Einhorn Center for Community Engagement to celebrate excellence in local and global university-community partnerships.
For talkative midshipman fish, the midbrain plays a key role in patterning trains of sounds and may serve as a model for how mammals, including humans, control vocal expression.
Members of the Weill Cornell Medical College Class of 2024 learned on national Match Day where they will be doing their internship and residency training – setting the stage for the next several years of their medical careers and lives.
An experimental mRNA vaccine against human cytomegalovirus, a common virus that can infect babies during pregnancy, elicited some of the most promising immune responses to date of any vaccine candidate, according to a study by Weill Cornell Medicine investigators.
A multicenter, phase 3 clinical trial has found that apixaban is no more effective than aspirin at preventing a second stroke in patients diagnosed with a milder, related condition called atrial cardiopathy, according to new research.
Fungal biologist Lori Huberman will use a $1.9 million grant from the National Institutes of Health to study how fungi sense and use nutrients, basic research with potential applications for treatment of cancer, obesity, Type 2 diabetes and fungal infections.